Applied Therapeutics, Inc. (NASDAQ:APLT) is advancing govorestat to treat the rare metabolic disease classic galactosemia. Children inherit the disease, which results in the inability to metabolize galactose. Eventually, galactose converts to a toxic and aberrant metabolite named galactitol.